MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081760 A) filed by Adc Therapeutics Sa on July 02, 2026, for Anti-Psma Antibody Drug Conjugates Comprising Exatecan.
Inventors include Hogg, Paul; Veillard, Nicolas; and Van Berkel, Patricius Hendrikus Cornelis.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: This disclosure relates to antibody conjugates comprising an antibody that binds specifically to the PSMA protein, conjugated to an Exatecan, and associated therapeutic uses.
Disclaimer: Curated by HT Syndication....